Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Leases (2019 - 2025)

Historic Current Leases for Sunshine Biopharma (SBFM) over the last 5 years, with Q3 2025 value amounting to $218053.0.

  • Sunshine Biopharma's Current Leases rose 8756.76% to $218053.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $218053.0, marking a year-over-year increase of 8756.76%. This contributed to the annual value of $207756.0 for FY2024, which is 7507.04% up from last year.
  • Sunshine Biopharma's Current Leases amounted to $218053.0 in Q3 2025, which was up 8756.76% from $222496.0 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Current Leases ranged from a high of $222496.0 in Q2 2025 and a low of $114452.0 during Q2 2024
  • In the last 4 years, Sunshine Biopharma's Current Leases had a median value of $121724.5 in 2023 and averaged $150948.0.
  • In the last 5 years, Sunshine Biopharma's Current Leases crashed by 629.9% in 2024 and then surged by 9440.11% in 2025.
  • Over the past 4 years, Sunshine Biopharma's Current Leases (Quarter) stood at $123026.0 in 2022, then fell by 3.54% to $118670.0 in 2023, then surged by 75.07% to $207756.0 in 2024, then rose by 4.96% to $218053.0 in 2025.
  • Its Current Leases was $218053.0 in Q3 2025, compared to $222496.0 in Q2 2025 and $213983.0 in Q1 2025.